Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Shephard

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 12, 2020
Flavin-Containing Monooxygenase 1 Catalyzes the Production of Taurine from HypotaurineSunil Veeravalli, Ian R Phillips, Rafael T Freire, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|September 6, 2012
Clinical features of bladder cancer in primary careElizabeth A Shephard, Sally Stapley, Richard D Neal, et al.
Computational and Structural Biotechnology Journal|April 19, 2016
A guide to the identification of metabolites in NMR-based metabonomics/metabolomics experimentsAnthony C Dona, Michael Kyriakides, Flora Scott, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|January 28, 2015
Quantifying the risk of multiple myeloma from symptoms reported in primary care patients: a large case-control study using electronic recordsElizabeth A Shephard, Richard D Neal, Peter Rose, et al.
Family Practice|December 21, 2020
Quantifying the impact of pre-existing conditions on the stage of oesophagogastric cancer at diagnosis: a primary care cohort study using electronic medical recordsMyra Quiroga, Elizabeth A Shephard, Luke T A Mounce, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|March 29, 2017
Clinical features of bowel disease in patients aged <50 years in primary care: a large case-control studySally A Stapley, Greg P Rubin, Deborah Alsina, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 25, 2008
Human flavin-containing monooxygenase 2.1 catalyzes oxygenation of the antitubercular drugs thiacetazone and ethionamideAsvi A Francois, Clinton R Nishida, Paul R Ortiz de Montellano, et al.
Pharmaceuticals (Basel, Switzerland)|April 13, 2013
Metabolism and pharmacokinetics of the anti-tuberculosis drug ethionamide in a flavin-containing monooxygenase null mouseAmy L Palmer, Virginia L Leykam, Andrew Larkin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 25, 2017
Identification of Flavin-Containing Monooxygenase 5 (FMO5) as a Regulator of Glucose Homeostasis and a Potential Sensor of Gut BacteriaFlora Scott, Sandra G Gonzalez Malagon, Brett A O'Brien, et al.
Biochemical Pharmacology|May 6, 2014
The phenotype of a flavin-containing monooyxgenase knockout mouse implicates the drug-metabolizing enzyme FMO1 as a novel regulator of energy balanceSunil Veeravalli, Bilal A Omar, Lyndsey Houseman, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 12, 2020
Flavin-Containing Monooxygenase 1 Catalyzes the Production of Taurine from HypotaurineSunil Veeravalli, Ian R Phillips, Rafael T Freire, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|September 6, 2012
Clinical features of bladder cancer in primary careElizabeth A Shephard, Sally Stapley, Richard D Neal, et al.
Computational and Structural Biotechnology Journal|April 19, 2016
A guide to the identification of metabolites in NMR-based metabonomics/metabolomics experimentsAnthony C Dona, Michael Kyriakides, Flora Scott, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|January 28, 2015
Quantifying the risk of multiple myeloma from symptoms reported in primary care patients: a large case-control study using electronic recordsElizabeth A Shephard, Richard D Neal, Peter Rose, et al.
Family Practice|December 21, 2020
Quantifying the impact of pre-existing conditions on the stage of oesophagogastric cancer at diagnosis: a primary care cohort study using electronic medical recordsMyra Quiroga, Elizabeth A Shephard, Luke T A Mounce, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|March 29, 2017
Clinical features of bowel disease in patients aged <50 years in primary care: a large case-control studySally A Stapley, Greg P Rubin, Deborah Alsina, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 25, 2008
Human flavin-containing monooxygenase 2.1 catalyzes oxygenation of the antitubercular drugs thiacetazone and ethionamideAsvi A Francois, Clinton R Nishida, Paul R Ortiz de Montellano, et al.
Pharmaceuticals (Basel, Switzerland)|April 13, 2013
Metabolism and pharmacokinetics of the anti-tuberculosis drug ethionamide in a flavin-containing monooxygenase null mouseAmy L Palmer, Virginia L Leykam, Andrew Larkin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 25, 2017
Identification of Flavin-Containing Monooxygenase 5 (FMO5) as a Regulator of Glucose Homeostasis and a Potential Sensor of Gut BacteriaFlora Scott, Sandra G Gonzalez Malagon, Brett A O'Brien, et al.
Biochemical Pharmacology|May 6, 2014
The phenotype of a flavin-containing monooyxgenase knockout mouse implicates the drug-metabolizing enzyme FMO1 as a novel regulator of energy balanceSunil Veeravalli, Bilal A Omar, Lyndsey Houseman, et al.
Pageof 7